10.1371/journal.pone.0161313.g005
Kyle E. Korolowicz
Kyle E.
Korolowicz
Radhakrishnan P. Iyer
Radhakrishnan
P. Iyer
Stefanie Czerwinski
Stefanie
Czerwinski
Manasa Suresh
Manasa
Suresh
Junming Yang
Junming
Yang
Seetharamaiyer Padmanabhan
Seetharamaiyer
Padmanabhan
Anjaneyulu Sheri
Anjaneyulu
Sheri
Rajendra K. Pandey
Rajendra K.
Pandey
Jeffrey Skell
Jeffrey
Skell
Judith K. Marquis
Judith K.
Marquis
Bhaskar V. Kallakury
Bhaskar V.
Kallakury
Robin D. Tucker
Robin D.
Tucker
Stephan Menne
Stephan
Menne
SB 9200 treatment is associated with dose-dependent, transient increases of SDH but not of other liver enzymes.
Public Library of Science
2016
SB 9200 treatment
HBV
SB 9200 Treatment
Host Innate Immunity Associated
serum WHV surface antigen
hepatitis B virus
SB 9200
1.6 log 10 declines
IFN
sensor proteins
NOD
RNA
woodchuck hepatitis virus
3.7 log 10 reductions
serum WHV DNA
2016-08-23 17:30:01
Figure
https://plos.figshare.com/articles/figure/SB_9200_treatment_is_associated_with_dose-dependent_transient_increases_of_SDH_but_not_of_other_liver_enzymes_/3754305
<p>Changes in mean serum levels of SDH, AST and ALT in response to SB 9200 treatment at a low (<b>A</b>) or high dose (<b>B</b>). Changes in mean serum WHV DNA relative to T<sub>0</sub> is plotted on the left y-axis. Error bars represent the standard error of the mean.</p>